Age and IL-15 levels were both predictors of early atherosclerosis in this population of obese patients with NAFLD, suggesting a possible role of this cytokine in the atherosclerosis process. This evidence concerns the gene IL15 and metabolic dysfunction-associated steatotic liver disease.